My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Vijaya Bank vaults after stellar Q4 outcome
May 09,2017

The result was announced during market hours today, 9 May 2017.

Meanwhile, the S&P BSE Sensex was up 1.30 points at 29,927.45

On the BSE, 24.09 lakh shares were traded on the counter as against the average daily volumes of 2.69 lakh shares in the past one quarter. The stock hit a high of Rs 97.40 in intraday trade, which is 52-week high for the counter. The stock hit a low of Rs 89.90 in intraday trade. The stock had hit a 52-week low of Rs 29.65 on 1 June 2016.

The mid-cap state-run bank has equity capital of Rs 998.85 crore. Face value per share is Rs 10.

The banks gross non-performing assets (NPAs) stood at Rs 6381.78 crore as on 31 March 2017 as against Rs 6304.65 crore as on 31 December 2016 and Rs 6027.07 crore as on 31 March 2016.

The ratio of gross NPAs to gross advances stood at 6.59% as on 31 March 2017 as against 6.98% as on 31 December 2016 and 6.64% as on 31 March 2016.

The ratio of net NPAs to net advances stood at 4.36% as on 31 March 2017 as against 4.74% as on 31 December 2016 and 4.81% as on 31 March 2016.

The Government of India held 70.33% stake in the bank as at 31 March 2017.

Powered by Capital Market - Live News

Godrej Consumer Products surges after robust Q4 results
May 09,2017

The result was announced during trading hours today, 9 May 2017.

Meanwhile, the S&P BSE Sensex was up 8.24 points, or 0.03% to 29,934.39.

On the BSE, 2.08 lakh shares were traded in the counter so far, compared with average daily volumes of 10,236 shares in the past one quarter. The stock had hit a high of Rs 1,956.20 so far during the day, which is also a record high for the counter. The stock had hit a low of Rs 1,761.55 so far during the day. The stock hit a 52-week low of Rs 1,285.55 on 15 November 2016.

The stock had outperformed the market over the past one month till 8 May 2017, rising 3.53% compared with 0.74% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 11.52% as against Sensexs 5.61% rise.

The large-cap FMCG company has equity capital of Rs 34.06 crore. Face value per share is Re 1.

Consolidated EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 21% to Rs 551 crore in Q4 March 2017 over Q4 March 2016.

Godrej Consumer Products said that its board approved issuing one bonus equity share of Re 1 each for every one fully paid-up equity share held (1:1).

Godrej Consumer Products is a leading FMCG company. The company is building a presence in 3 emerging markets (Asia, Africa, Latin America) across 3 categories (home care, personal wash, hair care). It ranks among the largest household insecticide and hair care players in emerging markets.

Powered by Capital Market - Live News

Trident declines after reporting Q4 results
May 09,2017

The result was announced during market hours today, 9 May 2017.

Meanwhile, the S&P BSE Sensex was down 11.75 points, or 0.04% at 29,937.90. The S&P BSE Mid-cap index was up 27.09 points, 0.18% at 14,819.69.

On the BSE, 13.86 lakh shares were traded on the counter so far as against the average daily volumes of 3.03 lakh shares in the past one quarter. The stock had hit a high of Rs 92.30 so far during the day, which is also its record high. The stock had hit a low of Rs 83.50 so far during the day.

The stock had hit a 52-week low of Rs 42 on 4 August 2016. The stock had outperformed the market over the past one month till 8 May 2017, advancing 11.67% compared with the Sensexs 0.74% rise. The scrip had also outperformed the market over the past one quarter advancing 27.13% as against the Sensexs 5.78% rise.

The mid-cap company has equity capital of Rs 509.58 crore. Face value per share is Rs 10.

Tridents net profit spurted 63.56% to Rs 99.66 crore on 31.9% increase in total revenue from operations to Rs 1281.10 crore in Q4 March 2017 over Q4 March 2016.

The companys bottom line growth in Q4 March 2017 was boosted by a massive jump in other income (non-operating income). Other income galloped 603% to Rs 49 crore in Q4 March 2017 over Q4 March 2016.

Shares of Trident had witnessed an impressive rally prior to the announcement of the companys results. The stock had surged 9.12% in the preceding five trading sessions to settle at Rs 90.90 yesterday, 8 May 2017, from its closing of Rs 83.30 on 28 April 2017.

Meanwhile, the company during market hours today, 9 May 2017 said that CRISIL has upgraded its rating on the long term bank facilities of Trident to CRISIL A+/stable from CRISIL A/Stable. The rating on the short-term facility has been reaffirmed at CRISIL A1.

Trident is a leading manufacturer and exporter of home textiles & paper products.

Powered by Capital Market - Live News

Lupin declines on buzz Aurangabad unit receives USFDA observations
May 09,2017

Meanwhile, the S&P BSE Sensex was up 20.64 points, or 0.07% to 29,946.79.

On the BSE, 1.66 lakh shares were traded in the counter so far, compared with average daily volumes of 82,033 shares in the past one quarter. The stock had hit a high of Rs 1,289.95 so far during the day. The stock had hit a low of Rs 1,242.50 so far during the day, which is also a 52-week low for the counter. The stock hit a 52-week high of Rs 1,750 on 29 July 2016.

The stock had underperformed the market over the past one month till 8 May 2017, falling 9.27% compared with 0.74% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.86% as against Sensexs 5.61% rise.

The large-cap company has equity capital of Rs 90.33 crore. Face value per share is Rs 2.

According to media reports, the US Food and Drug Administration (FDA) issued eight observations for Lupins Aurangabad unit, which was inspected between 17th and 26th April 2017.

Lupins consolidated net profit rose 20.7% to Rs 633.11 crore on 31.5% increase in net sales to Rs 4404.94 crore in Q3 December 2016 over Q3 December 2015. The company will declare Q4 results on 24 May 2017.

Lupin is a pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Powered by Capital Market - Live News

Dena Bank slips after dismal Q4 earnings
May 09,2017

The result was announced during trading hours today, 9 May 2017.

Meanwhile, the S&P BSE Sensex was up 17.57 points, or 0.06% to 29,943.72.

On the BSE, 25.24 lakh shares were traded in the counter so far, compared with average daily volumes of 3.20 lakh shares in the past one quarter. The stock had hit a high of Rs 50 and a low of Rs 44.30 so far during the day. The stock hit a 52-week high of Rs 50 on 9 May 2017. The stock hit a 52-week low of Rs 28.05 on 24 May 2016.

The stock had outperformed the market over the past one month till 8 May 2017, rising 20.54% compared with 0.74% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 18.13% as against Sensexs 5.61% rise.

The mid-cap state-run bank has equity capital of Rs 787.15 crore. Face value per share is Rs 10.

Dena Banks total income fell 8.46% to Rs 2612.08 crore in Q4 March 2017 over Q4 March 2016.

The banks gross non-performing assets (NPAs) stood at Rs 12618.73 crore as on 31 March 2017 as against Rs 11301.78 crore as on 30 December 2016 and Rs 8560.49 crore as on 31 March 2016.

The ratio of gross NPAs to gross advances stood at 16.27% as on 31 March 2017 as against 14.79% as on 31 December 2016 and 9.98% as on 31 March 2016.

The ratio of net NPAs to net advances stood at 10.66% as on 31 March 2017 as against 9.52% as on 31 December 2016 and 6.35% as on 31 March 2016.

The banks provisions and contingencies (excluding tax provisions) rose 7.89% to Rs 972.04 crore in Q4 March 2017 over Q4 March 2016.

Provision coverage ratio of the bank was at 50.56% as on 31 March 2017.

Government of India holds 68.55% stake in Dena Bank (as on 31 March 2017).

Powered by Capital Market - Live News

Titan Company drops after large bulk deal
May 09,2017

Meanwhile, the S&P BSE Sensex was up 29.26 points or 0.1% at 29,955.41

Bulk deal boosted volume on the scrip. On the BSE, 31.66 lakh shares were traded on the counter so far as against the average daily volumes of 74,016 shares in the past one quarter. The stock had hit a high of Rs 484.45 and a low of Rs 465.70 so far during the day. The stock had hit a 52-week low of Rs 296.30 on 21 November 2016. The stock had hit a record high of Rs 504 on 5 May 2017.

The stock had underperformed the market over the past one month till 8 May 2017, falling 0.42% compared with 0.74% rise in the Sensex. The scrip, however, outperformed the market in past one quarter, gaining 22.95% as against Sensexs 5.61% rise.

The large-cap company has equity capital of Rs 88.78 crore. Face value per share is Re 1.

Titan Companys net profit rose 13.09% to Rs 255.75 crore on 13.43% rise in total income to Rs 3904.82 crore in Q3 December 2016 over Q3 December 2015.

Titan Companys main business lines are watches, jewellery and eyewear.

Powered by Capital Market - Live News

Volumes jump at Atul counter
May 09,2017

Atul clocked volume of 1.54 lakh shares by 13:53 IST on BSE, a 64.99-times surge over two-week average daily volume of 2,000 shares. The stock rose 0.48% to Rs 2,461.60.

Titan Company notched up volume of 31.66 lakh shares, a 55.85-fold surge over two-week average daily volume of 57,000 shares. The stock lost 2.79% to Rs 470.20.

ABB India saw volume of 1.91 lakh shares, a 28.73-fold surge over two-week average daily volume of 7,000 shares. The stock surged 10.22% to Rs 1,545.

Tech Mahindra clocked volume of 44.80 lakh shares, a 28.52-fold surge over two-week average daily volume of 1.57 lakh shares. The stock rose 1.6% to Rs 427.75.

Varun Beverages saw volume of 6.06 lakh shares, a 24.82-fold rise over two-week average daily volume of 24,000 shares. The stock rose 0.8% to Rs 496.

Powered by Capital Market - Live News

Aarey Drugs gains after winning export order
May 09,2017

The announcement was made during trading hours today, 9 May 2017.

Meanwhile, the S&P BSE Sensex was up 71.13 points, or 0.24% to 29,997.28.

On the BSE, 1.50 lakh shares were traded in the counter so far, compared with average daily volumes of 1.41 lakh shares in the past one quarter. The stock had hit a high of Rs 108 and a low of Rs 105 so far during the day. The stock hit a record high of Rs 109.80 on 28 April 2017. The stock hit a 52-week low of Rs 36 on 10 May 2016.

The stock had underperformed the market over the past one month till 8 May 2017, rising 0.67% compared with 0.74% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 22.77% as against Sensexs 5.61% rise.

The small-cap company has equity capital of Rs 18.08 crore. Face value per share is Rs 10.

Aarey Drugs & Pharmaceuticals said it received first commercial export order for 20 metric tons of Thiobromine from Germany. The order will be executed by 30 June 2017.

Net profit of Aarey Drugs & Pharmaceuticals rose 775% to Rs 1.75 crore on 51.60% rise in net sales to Rs 96.01 crore in Q3 December 2016 Q3 December 2015.

Aarey Drugs & Pharmaceuticals is one of the rising manufacturer representatives and suppliers of pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, APIs drugs, food colours and flavours.

Powered by Capital Market - Live News

ABB India leads gainers on BSEs A group
May 09,2017

ABB India rose 10.36% at Rs 1,547. The stock topped the gainers in A group. On the BSE, 1.79 lakh shares were traded on the counter so far as against the average daily volumes of 6,653 shares in the past two weeks.

Godrej Consumer Products rose 7.12% at Rs 1,883.15. The stock was the second biggest gainer in A group. On the BSE, 96,000 shares were traded on the counter so far as against the average daily volumes of 17,000 shares in the past two weeks.

CG Power and Industrial Solutions rose 6.47% at Rs 81.50. The stock was the third biggest gainer in A group. On the BSE, 6.04 lakh shares were traded on the counter so far as against the average daily volumes of 2.12 lakh shares in the past two weeks.

Housing Development & Infrastructure (HDIL) rose 6.13% at Rs 98.65. The stock was the fourth biggest gainer in A group. On the BSE, 52.76 lakh shares were traded on the counter so far as against the average daily volumes of 22.61 lakh shares in the past two weeks.

Siemens rose 4.53% at Rs 1,417.10. The stock was the fifth biggest gainer in A group. On the BSE, 76,000 shares were traded on the counter so far as against the average daily volumes of 20,000 shares in the past two weeks.

Powered by Capital Market - Live News

CMI gains after new order win
May 09,2017

The announcement was made after market hours yesterday, 8 May 2017.

Meanwhile, the S&P BSE Sensex was 4.54 points or 0.02% at 29,930.69. The BSE Small-Cap index was up 90.19 points, or 0.58% to 15,552.77.

On BSE, so far 17,000 shares were traded in the counter as against average daily volume of 61,346 shares in the past one quarter. The stock hit a high of Rs 214.30 and a low of Rs 211 so far during the day. The stock had hit a 52-week high of Rs 260 on 3 June 2016. The stock had hit a 52-week low of Rs 118.10 on 9 November 2016.

The stock had outperformed the market over the past one month till 8 May 2017, rising 14.41% compared with 0.74% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 14.79% as against Sensexs 5.61% rise.

The small-cap company has equity capital of Rs 15.03 crore. Face value per share is Rs 10.

CMI won an order from Gujarat Energy Transmission Corporation (GETCO) for supply of 66KV XLPE cables. The order is revenue accretive and will be delivered within two quarters of the year ending 31 March 2018 (FY 2018). CMI recently started commercial production at its newly acquired facility at Baddi, Himachal Pradesh, which was a subsidiary of General Cable Corporation. The cables for the new order will also be manufactured at the new facility.

CMI chairman Amit Jain said that currently over 12% of the companys total revenue comes from the power sector and it expects that around 15% of revenues by FY 2019 will be from this segment.

CMIs consolidated net profit dropped 57.59% to Rs 2.04 crore on 12.46% growth in net sales to Rs 74.72 crore in Q3 December 2016 over Q3 December 2015.

CMI is engaged in manufacturing of special type of cables as per national/international specifications to meet the critical requirements of its customers.

Powered by Capital Market - Live News

Gillette India hits 52-week high after good Q3 results
May 09,2017

Meanwhile, the S&P BSE Sensex was up 18.22 points, or 0.06% at 29,944.37.

On the BSE, 4,390 shares were traded on the counter so far as against the average daily volumes of 8,467 shares in the past one quarter. The stock had hit a high of Rs 5,008.60 so far during the day, which is also its 52-week high. The stock had hit a low of Rs 4,802.70 so far during the day.

The stock had hit a 52-week low of Rs 4,025 on 28 February 2017. The stock had outperformed the market over the past one month till 8 May 2017, advancing 15.87% compared with the Sensexs 0.74% rise. The scrip had also outperformed the market over the past one quarter advancing 15.13% as against the Sensexs 5.78% rise.

The large-cap company has equity capital of Rs 32.59 crore. Face value per share is Rs 10.

Shares of Gillette India have rallied 12.47% in two trading sessions from its close of Rs 4,408.55 on 5 May 2017, after the company on Saturday, 6 May 2017 reported good Q3 March 2017 results. The stock had surged 9.09% to settle at Rs 4,809.20 yesterday, 8 May 2017.

Gillette Indias net profit rose 30.5% to Rs 105.82 crore on 15.9% increase in net sales to Rs 524.89 crore in Q3 March 2017 over Q3 March 2016.

Gillette India is engaged in the manufacturing and sale of branded packaged fast moving consumer goods in the grooming and oral care businesses.

Powered by Capital Market - Live News

Bharti Infratel gains after Q4 results
May 09,2017

The result was announced after market hours yesterday, 8 May 2017.

Meanwhile, the S&P BSE Sensex was up 31.14 points, or 0.10% to 29,957.29.

On the BSE, 94,557 shares were traded in the counter so far, compared with average daily volumes of 71.99 lakh shares in the past one quarter. The stock had hit a high of Rs 370.70 and a low of Rs 356 so far during the day.

The stock hit a 52-week high of Rs 412.55 on 28 July 2016. The stock hit a 52-week low of Rs 283.10 on 28 February 2017.

The stock had outperformed the market over the past one month till 8 May 2017, rising 4.75% compared with 0.74% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 20.54% as against Sensexs 5.61% rise.

The large-cap company has equity capital of Rs 1849.61 crore. Face value per share is Rs 10.

Consolidated EBITDA (earnings before interest, taxes, depreciation and amortization) rose 8% to Rs 1585 crore in Q4 March 2017 over Q4 March 2016.

On a consolidated basis, Bharti Infratels net profit rose 22.23% to Rs 2747 crore on 9.47% increase in net sales to Rs 6084.70 crore in the year ended March 2017 over the year ended March 2016.

Consolidated EBITDA rose 9% to Rs 5942 crore in the year ended March 2017 over the year ended March 2016.

Bharti Infratel is one of the leading providers of tower and related infrastructure. It deploys, owns and manages telecom towers and communication structures, for various mobile operators.

Powered by Capital Market - Live News

Mangalam Drugs gains after good Q4 result
May 09,2017

The result was announced after market hours yesterday, 8 May 2017.

Meanwhile, the BSE Sensex was up 32.18 points, or 0.11%, to 29,958.33. The BSE Small-Cap index was up 91.93 points, or 0.59% to 15,554.51.

On the BSE, so far 44,000 shares were traded in the counter, compared with average daily volumes of 40,436 shares in the past one quarter. The stock had hit a high of Rs 202 and a low of Rs 196 so far during the day. The stock hit a 52-week high of Rs 239.90 on 10 May 2016. The stock hit a 52-week low of Rs 122.90 on 22 November 2016.

The stock had outperformed the market over the past one month till 8 May 2017, rising 31.55% compared with 0.74% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 22.58% as against Sensexs 5.61% rise.

The small-cap company has equity capital of Rs 15.83 crore. Face value per share is Rs 10.

Mangalam Drugs & Organics manufactures active pharma ingredients (APIs), intermediates and specialty chemicals.

Powered by Capital Market - Live News

Tata Sponge shines after getting approval for hiking production capacity
May 09,2017

The announcement was made after market hours yesterday, 8 May 2017.

Meanwhile, the S&P BSE Sensex was up 18.66 points or 0.06% at 29,944.81. The S&P BSE Small-Cap index was up 71.05 points or 0.46% at 15,533.63.

On the BSE, 34,000 shares were traded on the counter so far as against the average daily volumes of 92,054 shares in the past one quarter. The stock hit a high of Rs 878 and a low of Rs 864.25 so far during the day. The stock had hit a 52-week high of Rs 900 on 11 April 2017 and a 52-week low of Rs 474.95 on 9 November 2016.

The stock had outperformed the market over the past one month till 8 May 2017, rising 17.63% compared with 0.74% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 38.83% as against Sensexs 5.61% rise.

The small-cap company has equity capital of Rs 15.40 crore. Face value per share is Rs 10.

Tata Sponge Iron received environment clearance from Ministry of Environment, Forest & Climate Change, Government of India, for enhancement of DRI production by 35,000 TPA i.e. from 3,90,000 TPA to 4,25,000 TPA in the existing facility located at Bileipada, district Keonjhat, Odisha.

Tata Sponge Irons consolidated net profit surged 62.1% to Rs 21.20 crore on 19.1% growth in net sales to Rs 167.17 crore in Q4 March 2017 over Q4 March 2016.

Tata Sponge Iron is a sponge iron manufacturer. Tata Steel is the promoter of Tata Sponge Iron. Tata Steel owned 54.5% stake in the company end March 2017.

Powered by Capital Market - Live News

S Chand and Company trades at small premium
May 09,2017

The stock debuted at Rs 707, a premium of 5.52% to the initial public offer (IPO) price. So far the stock hit a high of Rs 707 and low of Rs 658. On BSE, so far 10.24 lakh shares were traded on the counter.

The IPO closed on 28 April 2017. It was subscribed 59.49 times, with total bids for 45.72 crore shares. The qualified institutional buyers (QIBs) category was subscribed 44.27 times. The non institutional investors category was subscribed 204.65 times. The retail individual investors (RIIs) category was subscribed 6.07 times.

S Chand and Company on 25 April 2017 had raised Rs 219 crore from 15 anchor investors by selling 32.62 lakh shares. The shares were allotted to the anchor investors at Rs 670 per share, the top end of the Rs 660 to Rs 670 per share price band for the IPO.

S Chand and Companys IPO consisted of a fresh issue aggregating up to Rs 325 crore and an offer for sale of up to 60.23 lakh equity shares by the selling shareholders.

The net proceeds from the fresh issue will be utilized towards the repayment of loans availed by the company and one of its subsidiaries, EPHL, which were utilized towards funding the acquisition of Chhaya. The proceeds will also be utilized towards repayment/prepayment, in full or in part, of certain loans availed of by the company and certain of its subsidiaries, VPHPL and NSHPL; and general corporate purposes.

The company reported consolidated net loss of Rs 88.48 crore on total revenue of Rs 150.80 crore in the nine months ended 31 December 2016.

S Chand and Company is a leading Indian education content company. The company delivers content, solutions and services across the education lifecycle through its K-12, higher education and early learning segments.

Powered by Capital Market - Live News